1 / 56

#42 Immunodeficiencies I

#42 Immunodeficiencies I. Immunology 297 September 9, 2015 Ikuo Tsunoda, MD, Ph.D. Department of Microbiology and Immunology LSUHSC E-mail: itsunoda@hotmail.com Homepage: http://tsunodalaboratory.web.fc2.com/. Concepts.

Download Presentation

#42 Immunodeficiencies I

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. #42 Immunodeficiencies I Immunology 297 September 9, 2015 Ikuo Tsunoda, MD, Ph.D. Department of Microbiology and Immunology LSUHSC E-mail: itsunoda@hotmail.com Homepage: http://tsunodalaboratory.web.fc2.com/

  2. Concepts Immunodeficiencies occur when one or more components of the immune system is defective Primary immunodeficiency disease (PID): Caused by a genetic mutation that affects any gene that controls the immune responses

  3. Concepts Immunodeficiencies occur when one or more components of the immune system is defective.

  4. Concepts Immunodeficiencies occur when one or more components of the immune system is defective. Secondary immunodeficiency: Acquired as a consequence of other diseases, or are secondary to environmental factors such as starvation, or are an adverse consequence of medical intervention eg., infectious agents malnutrition hematopoietic tumors transplants

  5. Immunodeficiency research Understand “normal” from “abnormal” or “abnormal” from “normal” • Gain insights into components of the immune system that are important in • Allergy • Abnormal proliferation of lymphocytes • Autoimmunity • Cancer • Infections • Interaction between different cell types contributes to the immune response and to the development of T and B cells • Redundancy of defense mechanisms against infections • A defect compensated by other components • Discovery of defective gene and molecular basis of immune responses, revealing new information about diagnosis, genetic counseling, and gene therapy

  6. Primary immunodeficiency diseases (PIDs or PIDDs) • Around 50,000 new cases of PID are diagnosed in the US each year • Up to 1 in 2000 live births carry PIDs • At infancy, there is a 5:1 predominance of males over females • Many of the PIDs are X-linked • With the exception of selective IgA deficiency (1:333 to 1:700), PIDs are rare • Agammaglobulinemia 1:50,000 • SCID 1:10,000 to 1:100,000 • Abnormalities of more than 120 distinct genes account for more than 150 different forms of PID (Gela et al., 2007) • The International Union of Immunological Societies (IUIS) Expert Committee for Primary Immunodeficiency updates a classification of PIDs every 2 years

  7. The consequence of the PID depends on the stage of development that is affected

  8. Primary immunodeficiencies (PIDs) • Identical clinical conditions are caused by mutations in different immune system genes • SCID caused by mutations in 12 different genes • Hyper IgM syndrome can result from 6 different gene mutations • Phenotypic presentation of mutations in a single gene can be quite different even within the same family • Important to understand that genotype does NOT equate to phenotype • eg., DiGeorge syndrome: • 85% of patients have exactly the same mutation • clinical presentation is very broad – • no heart defects severe congenital heart defects • normal immune system vs complete absence of T cells

  9. Primary immunodeficiency diseases (PIDs) • Although most PIDs are diagnosed in childhood, ~40% are not • diagnosed until adolescence or early adulthood

  10. Warning signs for PIDs • 8 or more otitis media infections per year • 2 or more serious sinus infections per year • 2 or more pneumonias per year • recurrent deep infections or infections in unusual areas • infections with opportunistic pathogens • persistent thrush in patients older than 1 year • family history of PID • family history of early childhood deaths • Thrush is Candida infection, characterized by white, adherent, painless, discrete or confluent patches in the mouth, tongue, or esophagus

  11. Determining defects in cellular immunity • Often present with: • Opportunistic infections [Pneumocystis jirovecii (previously called Pneumocystis carinii), Cryptococcus, Candida spp.] • Disseminated viral infections (CMV, EBV, VZV) • Failure to thrive, chronic diarrhea, persistent thrush • Clinical evaluations: • Complete blood count (CBC) with differential, lymphocyte subsets • Vaccine titers (eg., tetanus, diphtheria) • Ig levels (IgA, IgE, IgM, IgG) • T cell proliferation assays, (eg., PHA, ConA, PMA/ionomycin) • Skin testing (eg., Candida protein)

  12. Determining defects in humoral immunity • Often present with: • Recurrent sinopulmonary infections • Encapsulated bacteria (Haemophilus influenza, Pneumococcus spp., etc..) • Parasitic infections (Giardia) • Some virus infections (enteroviruses, papillomavirus) • Chronic diarrhea, poor growth • Clinical evaluations: • Vaccine titers (eg., tetanus, diphtheria) • Ig levels (IgA, IgE, IgM, IgG) • B cell subset analysis (eg., naïve, memory, etc..)

  13. Determining defects in phagocytosis • Often present with: • Recurrent abscesses, abscesses in unusual areas • Recurrent oral ulcers • Severe pneumonias • Catalase+ organisms (eg., Staph. aureus, Serratia, etc..) • Clinical evaluations: • CBC with differential • nitroblue tetrazolium (NBT) test for production of oxygen radicals

  14. The specific gene defect, the consequence for the immune system, and the resulting disease susceptibilities are listed for some common and some rare human immunodeficiency syndromes. Severe combined immunodeficiency (SCID) can be due to many different defects, as summarized in Figure 13.8. AID, activation induced cytidine deaminase; ATM, ataxia telangiectasia-mutated protein; EBV, Epstein–Barr virus; IKKγ, γ subunit of the kinase IKK; STAT3, signal transducer and activator of transcription 3; TAP, transporters associated with antigen processing; UNG, uracil-DNA glycosylase; WASP, Wiskott–Aldrich syndrome protein.

  15. April, 2013 report without non-immunological phenotypes Primary Immunodeficiency Expert Committee http://www.iuisonline.org/iuis/index.php/primary-immunodeficiency-expert-committee.html

  16. http://www.omim.org/ aFewer than 10 cases

  17. SCIDs: Severe Combined Immunodeficiencies • Typically the most severe types of immunodeficiencies. • Lethal within 6-12 months if not treated. SCID is often called "bubble boy disease" SCID became widely known during the 1970's and 80's, when the world learned of David Vetter, a boy with X-linked SCID, who lived for 12 years in a plastic, germ-free bubble

  18. "The Boy in the Plastic Bubble" Trailer http://www.youtube.com/watch?v=nO5PC-rBsK8 The Boy In The Plastic Bubble (1976): http://www.youtube.com/watch?v=Xs26c4FDOZY

  19. Seinfeld “The Bubble Boy”Season 4, episode 7

  20. Severe combined immunodeficiencies (SCID) • Disorders that affects both humoral and cell-mediated immunity • Deficiencies of both B and T cells or only T cells • Severe opportunistic infections, death during the first year of life unless given antibody and a bone marrow transplant • Lymphocyte precursor cell death due to purine metabolism defect • Defective signaling through the common g-chain- • dependent cytokine receptors • 3. Defective V(D)J recombination • 4. Defective pre-TCR/TCR signaling

  21. SCIDs: Severe Combined Immunodeficiencies • Disorders that affect T cells, and sometimes B cells and/or NK cells • No effect on myeloid or erythroid cells

  22. Mechanisms of SCID 1. Lymphocyte precursor cell death due to purine metabolism defect (Table 1.2iii, 1.5): ADA (adenosine deaminase) or PNP (purine neucleoside phosphorylase) deficiency results in an accumulation of toxic precursors, which affects developing T and B cells Purine Catabolism Pathway ADENOSINE ADA (adenosine deaminase) INOSINE GUANOSINE PNP (purine nucleoside phosphorylase) PNP (purine nucleoside phosphorylase) GUANINE HYPOXANTHINE Xanthine Oxidase XANTHINE Guanase Xanthine Oxidase URIC ACID

  23. Mechanisms of SCID 1. Lymphocyte precursor cell death due to purine metabolism defect: Adenosine deaminase (ADA) deficiency in 16% of SCID Adenosine metabolites lead to apoptosis of lymphocytes, which causes the immunodeficiency Result : variable, but often results in the absence of T cells, B cells, and NK cells Treatment: Bone marrow transplantation Enzyme replacement therapy polyethylene glycol-modified bovine ADA (PEG- ADA) weekly administration

  24. Mechanisms of SCID 2. Defective signaling through the common g-chain- dependent cytokine receptors (Table 1.1a) : Several cytokine receptors share the common g-chain (gc) subunit: IL-2, IL-4, IL-7, IL-9, IL-15, IL-21

  25. 2-8 Shared subunits in subfamiies of cytokine receptors • Common cytokine-receptor γ chain (γc) chain • Jak3 associates exclusively with γc chain • γc chain encoded on X chromosome, Jak3 on autosomal chromosome

  26. Maturation of NK cells requires TAM and IL-15R • TAM receptors (TYRO3, Axl, and Mer) expressed on immature NK cells, and their ligands, GAS6 and protein S are produced by bone-marrow stromal cells • Maturation of NK cells requires TAM and IL-15R

  27. Mechanisms of SCID 2. Defective signaling through the common g-chain- dependent cytokine receptors : Several cytokine receptors share the common g-chain (gc) subunit: IL-2, IL-4, IL-7, IL-9, IL-15, IL-21 Mutations in the common g-chain result in absence of both mature T cells and NK cells. This is the most frequent form of SCID – called SCID-X1 no T cells or NK cells normal or elevated number of B cells – abnormal immunoglobulin production

  28. Mechanisms of SCID 2. Defective signaling through the common g-chain- dependent cytokine receptors Because Janus kinase 3 (JAK3) mediates signaling from the gc receptors, mutations in JAK3 result in a SCID phenotype that is indistinguishable from SCID-X1 gc mutation: X-linked SCID JAK3 mutation: autosomal recessive SCID IL-7Rα chain-deficient SCID: T-B+NK+

  29. Common beta chain (βc) shared by IL-2R and IL-15R IL-15 Omenn syndrome

  30. Mechanisms of SCID 3. Defective V(D)J recombination (Table 1.2i) Mutations in either RAG-1 or RAG-2 genes impairs the development of T cells and B cells, but not NK cells.  T-B-NK+ SCID Mutations in proteins involved in non-homologous end joining repair pathway (eg., Artemis) prevent resolution of the rearrangement intermediates Radiation-sensitive SCID (RS-SCID)

  31. RAG-dependent V(D)J rearrangement Gene segments containing recombination signal sequences (RSS) undergo rearrangement beginning with the binding of RAG1, RAG2 RAG proteins introduce a DNA double-stranded break, permitting V, D, J gene rearrangement Artemis deficiency results in an inability to repair DNA after double-stranded cuts made by RAG Mice in which either of the RAG genes is knocked out, or which lack DNA-PKcs, Ku, or Artemis, suffer a complete block in lymphocyte development at the gene-rearrangement stage DNA-PKcs: DNA-dependent protein kinase catalytic subunit

  32. Omenn syndrome: leaky SCID (Table 1.29) • First described by Gilbert Omenn in 1965 • Chronic diarrhea, pneumonitis [Pneumocystis jirovecii (previously called Pneumocystis carinii), cytomegalovirus, parainfluenza], failure to thrive • Enlarged lymph nodes, hepatosplenomegaly (whereas SCID patients present with paucity or absence of lymph nodes) • Erythroderma, desquamation, alopecia, loss of eyebrows and eyelashes, hypereosinophilia, elevated serum IgE • Partial and impaired V(D)J recombinational activity • Hypomorphic mutations in either RAG1 or RAG2 • Small amount of RAG protein • Protein loss through the skin and the gut leads to generalized edema and metabolic disturbances • Inflammation in the skin • Fatal unless corrected by bone marrow transplantation

  33. Omenn syndrome: leaky SCID • T cell number is normal • Depressed T cell proliferation to antigens • Depressed humoral immunity • Elevated IgE level • NK cells are normal • Abnormal expansion of 1 or more Th2 type-cell clone, causing inflammation and tissue damage • Abnormal TCR rearrangement results in low-affinity limited repertoire TCRs and therefore skewed Th2 differentiation (weak TCR stimulation by itself can drive naive CD4 cells to differentiate into Th2 cells) • No regulatory T cells, no NKT, no IL-10

  34. Radiation-sensitive SCID (RS-SCID) Irradiation-sensitive SCID (IR-SCID) Defects in DNA proteins involved in repairing DNA double-strand breaks during antigen receptor rearrangement and by ionizing radiation Very few B and T cells because of a failure of DNA rearrangement Defects in the genes for Artemis, DNA protein-kinase catalytic subunit (DNA-PKcs) IV (Table 1.2ib and 1.2ic) [and DNA ligase IV (Table 1.29)] Patients develop cancer

  35. SCID mice DNA-dependent protein kinase (DNA-PK) composed of DNA-PK catalytic subunit (DNA-PKcs) and Ku heterodimer (Ku70:Ku80) DNA-PK:Artemis complex has nuclease activity and opens the DNA hairpin Mutation in a DNA protein kinase results in inability of precursor T and B cells to differentiate into mature cells Very commonly used for cellular immunology studies as recipient mice Immune precursors from humans can develop correctly in SCID mice implanted with human thymus tissue …. SCID-hu mice

  36. NOG mice: NOD-scid IL2rγnull • Discovery of CB-17-scid (formally Prkcscid) • No functional T or B cells • Mutation of DNA-dependent protein kinase (Prkdc) gene • Normal human hematopoietic cells could be developed (SCID-hu mice), which is difficult with nude mice (no thymus) • NOD-scid • Scid gene introduction into the NOD mice (noneobese diabetes model) • Reduced innate immunity derived from NOD mice: macrophage dysfunction, defect of complement hemolytic activity, reduced NK activity • Humanized mice: human immune system reconstituted from human hematopoietic stem cells in mice • NOD-scid IL2rγnull • Elimination of NK cells augment the engraftment of human cells in NOD-scid mice • Lack of NK cells, dendritic cell dysfunction, and other unknown deficiency due to inactivation of IL-2Rγ gene

  37. RAG2-/- γc- double mutant mice • Common cytokine receptor γ chain (γc) deficient mice • IL-2, 4, 7, 9, and 15R • Absence of NK, NKT and γδ T cells • Small number of poorly functioning B cells and αβ T cells • Double mutant mice are completely alymphoid (T-, B-, NK-) • No spontaneous tumor • Normal hematopoietic parameters

  38. Improvement of immunodeficient mice for humanized mice • Introduction of human growth or differentiation factor • Cross-reactivity of factors between mice and humans may influence human cell engraftment and differentiation • To differentiate and grow myeloid lineage cells: GM-CSF, IL-3, erythropoietin, thrombopoietin • Reconstruction of human secondary lymphoid organs: lymphotoxin, chemokines • Depletion of innate immune cells from immunodeficient mice • Macrophages, dendritic cells, mast cells, neutrophils • Transgenic technique, such as using diphtheria toxin • RNAi technique • Introduction of HLA gene • Lack of cell-to-cell interaction between human T, B cells and macrophages, since T cells are educated in the mouse thymus • HLA transgenic mice

  39. Mechanisms of SCID 4. Defective pre-TCR/TCR signaling: Mutations in critical signaling proteins, such as CD45, alter T cell development (Table 1.1d) (Table 1.1e, f, g, 1.6, 1.18) (Table 1.8) (Table 1.19)

  40. Mechanisms of SCID 4. Defective pre-TCR/TCR signaling : These are rare cases of SCID that are pure T cell deficiencies Failure of T cell development due to defective signaling through the pre-TCR during positive selection. Mutations include: CD3d , CD3e, CD3ζ(Table 1.1e, f, g) CD3γ(Table 1.6) CD45 (Table 1.1d)

  41. Similar defects, but not total SCIDs: Defective pre-TCR/TCR signaling : Mutations in signaling proteins such as ZAP-70 alter T cell development, but some T cells develop normally.

More Related